Weizhen Wu

945 total citations · 1 hit paper
28 papers, 728 citations indexed

About

Weizhen Wu is a scholar working on Surgery, Transplantation and Molecular Biology. According to data from OpenAlex, Weizhen Wu has authored 28 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Transplantation and 7 papers in Molecular Biology. Recurrent topics in Weizhen Wu's work include Renal Transplantation Outcomes and Treatments (10 papers), Transplantation: Methods and Outcomes (6 papers) and Renal Diseases and Glomerulopathies (2 papers). Weizhen Wu is often cited by papers focused on Renal Transplantation Outcomes and Treatments (10 papers), Transplantation: Methods and Outcomes (6 papers) and Renal Diseases and Glomerulopathies (2 papers). Weizhen Wu collaborates with scholars based in China, United States and United Kingdom. Weizhen Wu's co-authors include Ming Jen Tan, Shunliang Yang, Lianming Liao, Jinquan Cai, Xinhui Sun, Jin Chen, Feng Zheng, Xia Gao, Shari Messinger and Antonello Pileggi and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and The Journal of Urology.

In The Last Decade

Weizhen Wu

25 papers receiving 717 citations

Hit Papers

Induction Therapy With Autologous Mesenchymal Stem Cells ... 2012 2026 2016 2021 2012 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Induction Therapy With Autologous Mesenchymal Stem Cells in Living-Related Kidney Transplants
    2012 430 citations Ming Jen Tan, Weizhen Wu et al. JAMA profile →

Peers

Weizhen Wu
Takenori Ozaki Japan
Chérif Badid France
Sandra Villanueva Chile
A.M.A. Peeters Netherlands
Samantha Solini Italy
Akiko Tonooka Japan
Giovanni M. Frascà Italy
Ching-Fang Wu Taiwan
Elena Orsenigo Italy
Jorge Tchongue Australia
Takenori Ozaki Japan
Weizhen Wu
Citations per year, relative to Weizhen Wu Weizhen Wu (= 1×) peers Takenori Ozaki

Countries citing papers authored by Weizhen Wu

Since Specialization
Citations

This map shows the geographic impact of Weizhen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weizhen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weizhen Wu more than expected).

Fields of papers citing papers by Weizhen Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weizhen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weizhen Wu. The network helps show where Weizhen Wu may publish in the future.

Co-authorship network of co-authors of Weizhen Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Weizhen Wu. A scholar is included among the top collaborators of Weizhen Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weizhen Wu. Weizhen Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Weizhen, Peng Zhou, Li Zhao, et al.. (2025). Coptisine improves LPS-induced anxiety-like behaviors by regulating the Warburg effect in microglia via PKM2. Biomedicine & Pharmacotherapy. 183. 117837–117837. 5 indexed citations
2.
Tang, Jing, Xiaoyu Xu, Xuelin Huang, et al.. (2025). Causal relationship between gut microbiota and malignant lymphoma: a two-way two-sample mendelian randomization study. Translational Cancer Research. 14(3). 1982–1994.
3.
Wu, Weizhen, et al.. (2024). Mendelian randomization supports genetic liability to hospitalization for COVID-19 as a risk factor of pre-eclampsia. Frontiers in Cardiovascular Medicine. 11. 1327497–1327497.
4.
Wang, Rong, Ruicong Xue, Ting Shi, et al.. (2024). Personalized therapy guided by single‐cell transcriptomic analysis in relapsed and refractory KMT2A::MLLT10AML with extensive extramedullary infiltration: A case report. British Journal of Haematology. 205(4). 1444–1449. 1 indexed citations
5.
Wu, Zhixian, Shulin Huang, Shasha Li, et al.. (2024). Bone marrow mesenchymal stem cell and mononuclear cell combination therapy in patients with type 2 diabetes mellitus: a randomized controlled study with 8-year follow-up. Stem Cell Research & Therapy. 15(1). 339–339. 4 indexed citations
6.
Wu, Weizhen, et al.. (2023). Electroacupuncture for the treatment of cancer pain: a systematic review and meta-analysis of randomized clinical trials. SHILAP Revista de lepidopterología. 4. 1186506–1186506. 2 indexed citations
7.
8.
Shi, Daohua, et al.. (2018). CYP3A4 and GCK genetic polymorphisms are the risk factors of tacrolimus-induced new-onset diabetes after transplantation in renal transplant recipients. European Journal of Clinical Pharmacology. 74(6). 723–729. 9 indexed citations
9.
Li, Bin, Shilin Zhang, Weizhen Wu, et al.. (2017). Imidazolium-based ionic liquid-catalyzed hydrosilylation of imines and reductive amination of aldehydes using hydrosilane as the reductant. RSC Advances. 7(51). 31795–31799. 9 indexed citations
10.
Wu, Weizhen. (2014). Application Progress of Near Infrared Spectroscopy in Determination of Rice Characteristics. Yaredai zhiwu kexue. 1 indexed citations
11.
Zou, Yuhua, Zhixian Wu, Weizhen Wu, et al.. (2013). Protective effects of mesenchymal stromal cells on adriamycin-induced minimal change nephrotic syndrome in rats and possible mechanisms. Cytotherapy. 16(4). 471–484. 15 indexed citations
12.
Wu, Weizhen, Jie Tian, Chen Zhao, et al.. (2013). MULTI-SCALE ANALYSIS OF THE LONG-TERM TREND OF THE HYDROMETEOROLOGICAL VARIABLES IN THE UPPER REACH OF THE HEIHE RIVER,NORTHWEST CHINA. Marine Geology & Quaternary Geology. 33(4). 37–37. 4 indexed citations
13.
Tan, Ming Jen, Weizhen Wu, Xiumin Xu, et al.. (2012). Induction Therapy With Autologous Mesenchymal Stem Cells in Living-Related Kidney Transplants. JAMA. 307(11). 1169–1169. 430 indexed citations breakdown →
14.
Wang, Dong, Guojun Wu, Jinhua Chen, et al.. (2012). Predicting renal graft failure by sCD30 levels and de novo HLA antibodies at 1 year post-transplantation. Transplant Immunology. 26(4). 235–239. 6 indexed citations
15.
Wang, Dong, et al.. (2012). Post-transplant monitoring of soluble CD30 level as predictor of graft outcome: A single center experience from China. Transplant Immunology. 27(4). 146–150. 8 indexed citations
16.
17.
Wang, Dong, et al.. (2009). Pre-transplant soluble CD30 level as a predictor of not only acute rejection and graft loss but pneumonia in renal transplant recipients. Transplant Immunology. 22(3-4). 115–120. 18 indexed citations
18.
Wang, Dong, Guojun Wu, Weizhen Wu, et al.. (2007). Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection. Transplant Immunology. 17(4). 278–282. 22 indexed citations
19.
20.
Wu, Weizhen, et al.. (2006). Prediction of acute renal allograft rejection in early post-transplantation period by soluble CD30. Transplant Immunology. 16(1). 41–45. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takenori Ozaki Breakdown of academic impact, for papers by Chérif Badid Breakdown of academic impact, for papers by Sandra Villanueva Breakdown of academic impact, for papers by A.M.A. Peeters Breakdown of academic impact, for papers by Samantha Solini Breakdown of academic impact, for papers by Akiko Tonooka Breakdown of academic impact, for papers by Giovanni M. Frascà Breakdown of academic impact, for papers by Ching-Fang Wu Breakdown of academic impact, for papers by Elena Orsenigo Breakdown of academic impact, for papers by Jorge Tchongue
Rankless by CCL
2026